Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03232736 · ClinicalTrials.gov registry record
InterventiOn of Biventricular Pacemaker Function on ventrIcular Function Among Patients With LVAD's
A clinical trial, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- 22
- Enrollment target
NCT03232736: Completed study, sponsored by University of Colorado, Denver.
NCT03232736 is a clinical trial that has completed, run by University of Colorado, Denver. The registered enrollment target is 22 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03232736 has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- 22 participants
- Enrollment target
Study Summary
The primary reason the investigators are doing this study are to understand how the right side of the heart functions in heart failure patients with left ventricular assist devices (LVADs, or "mechanical hearts"). Second, the investigators are interested in understanding how different pacemaker settings influence function of the heart at rest and activity.
Primary Outcome
peak Vo2 measured by indirect calorimetry during cardiopulmonary exercise testing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2017-10-01 |
| Est. Completion | 2020-01-30 |
What the finished NCT03232736 record still lists
NCT03232736 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 22 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT03232736 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03232736 about?
NCT03232736 is a clinical study titled "InterventiOn of Biventricular Pacemaker Function on ventrIcular Function Among Patients With LVAD's". The primary reason the investigators are doing this study are to understand how the right side of the heart functions in heart failure patients with left ventricular assist devices (LVADs, or "mechanical hearts"). Second, the investigators are interested in understanding how different pacemaker sett...
What is the current status of trial NCT03232736?
This trial is currently completed. The enrollment target is 22 participants. The study started on 2017-10-01. Estimated completion is 2020-01-30.
Who is sponsoring clinical trial NCT03232736?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02508038 · 22 participants · Phase 1
Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors
- NCT03099356 · 22 participants · Phase 2
Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer
- NCT03676647 · 22 participants
Diagnostic DNA Methylation Signature in Diagnosing Thyroid Cancer After Fine-Needle Aspiration in Patients With Thyroid Nodules
- NCT04569591 · 22 participants · NA
DDAVP for Pituitary Adenoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI